GeoVax to Present Multi-Antigen COVID-19 Vaccine Clinical Data at September International Scientific ConferencesSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Announces Allowance of Patent Protecting Multi-Antigen COVID-19 Vaccine ConstructsExpands Intellectual Property Portfolio Supporting Next-Generation COVID-19 Vaccine Candidates
GeoVax to Present at the H.C. Wainwright 27th Annual Global Investment ConferenceSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Announces Allowance of Patent Protecting Multi-Antigen COVID-19 Vaccine ConstructsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Present at the Emerging Growth Conference on August 20, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Present at the Emerging Growth Conference on August 20, 2025Company to Provide Key Updates on GEO-MVA and Its Mpox Vaccine Development Program
GeoVax Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen VaccineSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Comments on HHS mRNA Vaccine Rollback: Urges Full Embrace of MVA-Based Multi-Antigen VaccineGEO-CM04S1 Offers Solution to Overcome HHS-Cited mRNA Deficiencies - Potentially Offering Broader, More Durable Protection
GeoVax Reports Second Quarter 2025 Financial Results and Provides Business UpdateGEO-MVA received favorable European regulatory guidance supporting streamlined development pathway
GeoVax to Advance Gedeptin(R) Into First-Line Therapy Neoadjuvant Combination Trial Following Landmark KEYNOTE-689 ResultsRevised Phase 2 Strategy Targets Event-Free Survival in Primary Head and Neck Cancer through Checkpoint Inhibitor Combination
GeoVax Urges Immediate Action on Pandemic Preparedness as Biodefense Gaps Expose Fragile Supply ChainsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Urges Immediate Action on Pandemic Preparedness as Biodefense Gaps Expose Fragile Supply ChainsWith Mpox spreading globally, COVID-19 variants evading immunity, and bipartisan leaders demanding U.S.-based solutions, GeoVax calls for urgent investment in domestic manufacturing and vaccine diversification
GeoVax Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed WHO Emergency DesignationSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Accelerates Development of GEO-MVA Vaccine Amid Expanding Global Mpox Crisis and Reaffirmed WHO Emergency DesignationEMA Scientific Guidance, Global Surge in Clade I Mpox, and Aid Shortfalls Drive Urgent Need for Scalable, Equitable Vaccine Solutions
GeoVax Reports Second Quarter 2025 Financial Results and Provides Business UpdateSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax Announces Research Program to Evaluate Needle-Free, Self-Administered GEO-MVA Vaccine Using Vaxxas Microarray Patch TechnologySearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Advance Gedeptin(R) Into First-Line Therapy Neoadjuvant Combination Trial Following Landmark KEYNOTE-689 ResultsSearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
GeoVax to Report Second Quarter 2025 Financial Results and Provide Corporate Update on July 28, 2025Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
